Psychiatric Medications and the Youth Population*

imageimageimage

While psychiatric medicines such as Lithium, Abilify and Risperidone exist designed specifically for younger consumers, pharmaceuticals need to create safer ones.  A young person’s brain isn’t fully developed until their early twenties.  The body as a whole should have the capacity to withstand medications. Presently, many youth experience toxicity, weakened bones, and neurological challenges from appropriate drug usage.  Kidney damage, at times irreversible, is one of the consequences from Lithium.

All medications have side effects and not every user will experience them.  However, side effects associated with psychotropic drugs can be greatly reduced with newer medicines targeted for this segment of the population.

*First-generation psychiatric drugs went on the market before the late 1980’s. These medications can result in neurological problems.  Second generation psychiatric drugs went on the market after the late 1980’s. These medications can result in weight gain, diabetes, elevated levels of cholesterol, and neurological problems. 

Vikki